Skip to Content


In the US, Palivizumab (palivizumab systemic) is a member of the drug class immune globulins and is used to treat Respiratory Syncytial Virus.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Categories

Antiviral agent


Monoclonal antibody

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal MEDI-493 gamma1-chain anti-respiratory syncytial virus protein F), disulfide wit human-mouse monoclonal MEDI-493 kappa-chain, dimer (WHO)

Foreign Names

  • Palivizumabum (Latin)
  • Palivizumab (German)
  • Palivizumab (French)
  • Palivizumab (Spanish)

Generic Names

Brand Names

  • Abbosynagis
  • Synagis
    Abbott, Argentina; Abbott, Australia; Abbott, Brazil; Abbott, Czech Republic; Abbott, Ecuador; Abbott, Georgia; Abbott, Oman; Abbott, Romania; Abbott, Serbia; Abbott, Slovakia; Abbott, Tunisia; Abbott, Taiwan; Abbott, South Africa; Abbott Laboratories de Chile, Chile; AbbVie, Austria; AbbVie, Belgium; AbbVie, Canada; AbbVie, Switzerland; AbbVie, Germany; AbbVie, Denmark; AbbVie, France; AbbVie, United Kingdom; AbbVie, Greece; AbbVie, Hong Kong; AbbVie, Croatia (Hrvatska); AbbVie, Hungary; AbbVie, Ireland; AbbVie, Italy; AbbVie, Japan; AbbVie, Latvia; AbbVie, Netherlands; AbbVie, Norway; AbbVie, New Zealand; AbbVie, Sweden; AbbVie, Singapore; AbbVie, Slovenia; AbbVie, Tunisia; AbbVie, Turkey; Abbvie Farmacéuticos, Mexico; AbbVie Inc., Bosnia & Herzegowina; AbbVie Polska, Poland; MedImmune, United States; Abbott Laboratories, Lithuania


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.